ARTICLE | Emerging Company Profile
Corporate Profile
March 12, 2007 7:00 AM UTC
Seattle, Wash.
Technology: Specific inhibitors of p110, a catalytic subunit of phosphoinositide 3-kinase (PI3K)...
Seattle, Wash.
Technology: Specific inhibitors of p110, a catalytic subunit of phosphoinositide 3-kinase (PI3K)...